News for Kintor Pharmaceutical Limited (9939.HK)

As Per SNS Insider, Alopecia Treatment Market Growth is Driven by Rising Demand for Hair Restoration Products, and Technological Advancements....

Key Takeaways: Kintor announced it will commercialize its KX-826 as an over-the-counter hair-loss drug, after it failed to show efficacy in clinical trials The new product could provide the company’s first recurring revenue, though it could face difficulty competing with regulator-approved products like Rogaine

GT20029 China Phase II Trial For AGA Reached Primary Endpoint

Kinto's drug has failed to show a significant hair-boosting effect in Phase III trials, dashing investors’ hopes for a ground-breaking treatment for baldness.

Suzhou, October 28, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the...

Suzhou, October 11, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that its...

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

/PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to 21 March 2023 in New Orleans, Louisiana,...

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

Key Takeaways: Cutia Therapeutics has filed for a Hong Kong listing, even as its losses grow following the launch of its first two hair loss drugs last year The company is backed by a number of big-name investors, including WuXi AppTec’s venture arm, Yunfeng Capital and Sequoia Capital By Emily Chan

/PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...